Biogen to Post Q2 2018 Earnings of $5.22 Per Share, Jefferies Group Forecasts


Equities researchers at Jefferies Group dropped their Q2 2018 EPS estimates for Biogen in a note issued to investors on Tuesday, April 24th. Jefferies Group analyst M. Yee now expects that the biotechnology company will post earnings per share of $5.22 for the quarter, down from their previous forecast of $6.31.



from Biotech News